ERGIC-3 Polyclonal Antibody

Rabbit Anti-ERGIC-3 Polyclonal Antibody

Product Specifications

Background

The ERGIC3 protein was also over-expressed in lung cancer tissues and cultured cells, and expression of ERGIC3 was correlated with the differentiated degree and histological type of lung cancer (PMID: 23374247) . The up-regulation of ERGIC3 could promote cellular migration and proliferation in vitro. ERGIC3 may play an active role in the development and progression of lung cancer (PMID: 23374247) . The MW of this protein is 50 kDa, and this antibody specially recognises the 50 kDa protein.

CAS Number

9007-83-4

Product Name Alternative

ERGIC3; C20orf47; ERV46; SDBCAG84; CGI-54; Endoplasmic reticulum-Golgi intermediate compartment protein 3; Serologically defined breast cancer antigen NY-BR-84

Gene ID

51614

Accession Number

Q9Y282

Reactivity

Human, Mouse

Immunogen

Synthesized peptide derived from the C-terminal region of human ERGIC-3 at AA range: 280-360

Clonality

Polyclonal

Tag

Endoplasmic reticulum-Golgi intermediate compartment protein 3

Applications

WB, IHC, IF, ELISA

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Molecular Weight

43kD

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

ERGIC-3 Polyclonal Antibody detects endogenous levels of ERGIC-3 protein.

Observed Molecular Weight

Formulation

Liquid solution

Buffer pH

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000; IHC 1:100-1:300; IF 1:200-1:1000; ELISA 1:20000; Not yet tested in other applications.

Other Product Names

ERGIC3; C20orf47; ERV46; SDBCAG84; CGI-54; Endoplasmic reticulum-Golgi intermediate compartment protein 3; Serologically defined breast cancer antigen NY-BR-84